Quattrocchi Elaena, Goldberg Tamara, Marzella Nino
Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Pharmacy.
Drugs Context. 2020 Jan 27;9:212607. doi: 10.7573/dic.212607. eCollection 2020.
Despite the advances in diabetes management, people with diabetes are not reaching their target glycemic goals. Healthcare professionals often fail to initiate, escalate, or de-intensify therapy when indicated. There are several organizations that provide guidance on the management of diabetes to assist the practitioner in achieving improved glycemic control, and this can cause confusion to the practitioner on which organizations' guidance to follow. Diabetes mellitus is associated with an elevated risk of cardiovascular disease, and there have been studies that suggest some antidiabetic medications increase cardiovascular risk and some reduce cardiovascular risk. Diabetes organizations recommend the individualization of treatment goals and choices of drug therapy that will be safe and effective. Healthcare professionals should be knowledgeable and equipped to decide on the best treatment regimen for each of their patients with type 2 diabetes (T2D) and be familiar with how to utilize the different organizations' philosophies in treating their patients.
尽管糖尿病管理取得了进展,但糖尿病患者仍未达到其血糖目标。医疗保健专业人员在有指征时常常未能启动、加强或减弱治疗。有几个组织提供糖尿病管理方面的指导,以帮助从业者实现更好的血糖控制,这可能会让从业者在遵循哪个组织的指导方面感到困惑。糖尿病与心血管疾病风险升高相关,并且有研究表明一些抗糖尿病药物会增加心血管风险,而一些则会降低心血管风险。糖尿病组织建议对治疗目标和药物治疗选择进行个体化,以确保安全有效。医疗保健专业人员应具备知识并能够为每位2型糖尿病(T2D)患者确定最佳治疗方案,并熟悉如何在治疗患者时运用不同组织的理念。